Epclusa 61958-2204
Generic: Velpatasvir And Sofosbuvir
Product NDC
61958-2204- Manufacturer
- Gilead Sciences, Inc.
- Dosage Form
- Pellet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 10, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA214187
Need to source Epclusa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sofosbuvir | 200 mg/1 |
| Velpatasvir | 50 mg/1 |
Drug Class
Hepatitis C Virus NS5A Inhibitor [EPC]Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]
Packaging Options(1)
28 PACKET in 1 CARTON (61958-2204-1) / 1 PELLET in 1 PACKET